JP2006502235A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502235A5
JP2006502235A5 JP2004568899A JP2004568899A JP2006502235A5 JP 2006502235 A5 JP2006502235 A5 JP 2006502235A5 JP 2004568899 A JP2004568899 A JP 2004568899A JP 2004568899 A JP2004568899 A JP 2004568899A JP 2006502235 A5 JP2006502235 A5 JP 2006502235A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
amino
heteroaryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004568899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502235A (ja
JP4518956B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/003823 external-priority patent/WO2004026863A1/en
Publication of JP2006502235A publication Critical patent/JP2006502235A/ja
Publication of JP2006502235A5 publication Critical patent/JP2006502235A5/ja
Application granted granted Critical
Publication of JP4518956B2 publication Critical patent/JP4518956B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004568899A 2002-09-18 2003-09-08 トランスフォーミング成長因子(tgf)阻害剤としての新規トリアゾールおよびオキサゾール化合物 Expired - Fee Related JP4518956B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41212002P 2002-09-18 2002-09-18
US47126503P 2003-05-16 2003-05-16
US48458103P 2003-07-02 2003-07-02
PCT/IB2003/003823 WO2004026863A1 (en) 2002-09-18 2003-09-08 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors

Publications (3)

Publication Number Publication Date
JP2006502235A JP2006502235A (ja) 2006-01-19
JP2006502235A5 true JP2006502235A5 (cg-RX-API-DMAC7.html) 2006-09-28
JP4518956B2 JP4518956B2 (ja) 2010-08-04

Family

ID=32034216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004568899A Expired - Fee Related JP4518956B2 (ja) 2002-09-18 2003-09-08 トランスフォーミング成長因子(tgf)阻害剤としての新規トリアゾールおよびオキサゾール化合物

Country Status (28)

Country Link
US (1) US7273936B2 (cg-RX-API-DMAC7.html)
EP (1) EP1542994B1 (cg-RX-API-DMAC7.html)
JP (1) JP4518956B2 (cg-RX-API-DMAC7.html)
KR (1) KR20050057415A (cg-RX-API-DMAC7.html)
CN (1) CN1681810A (cg-RX-API-DMAC7.html)
AP (1) AP2005003261A0 (cg-RX-API-DMAC7.html)
AR (1) AR041273A1 (cg-RX-API-DMAC7.html)
AT (1) ATE430147T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003256003A1 (cg-RX-API-DMAC7.html)
BR (1) BR0314383A (cg-RX-API-DMAC7.html)
CA (1) CA2499429C (cg-RX-API-DMAC7.html)
CO (1) CO5550473A2 (cg-RX-API-DMAC7.html)
CR (1) CR7743A (cg-RX-API-DMAC7.html)
DE (1) DE60327443D1 (cg-RX-API-DMAC7.html)
EA (1) EA200500354A1 (cg-RX-API-DMAC7.html)
ES (1) ES2323421T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050250A2 (cg-RX-API-DMAC7.html)
IS (1) IS7711A (cg-RX-API-DMAC7.html)
MA (1) MA27443A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05002332A (cg-RX-API-DMAC7.html)
NO (1) NO20051838L (cg-RX-API-DMAC7.html)
OA (1) OA12926A (cg-RX-API-DMAC7.html)
PA (1) PA8582701A1 (cg-RX-API-DMAC7.html)
PE (1) PE20040987A1 (cg-RX-API-DMAC7.html)
PL (1) PL375975A1 (cg-RX-API-DMAC7.html)
TW (1) TW200413362A (cg-RX-API-DMAC7.html)
UY (1) UY27978A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004026863A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039241A1 (es) * 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
UA80295C2 (en) * 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
CN1681805A (zh) * 2002-09-18 2005-10-12 辉瑞产品公司 作为转化生长因子(tgf)抑制剂的新的咪唑类化合物
AU2003259475A1 (en) * 2002-09-18 2004-04-08 Pfizer Products Inc. Pyrazole derivatives as transforming growth factor (TGF) inhibitors
PA8595001A1 (es) 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
GB0313914D0 (en) * 2003-06-16 2003-07-23 Smithkline Beecham Corp Compounds
MX2007001727A (es) * 2004-08-13 2007-04-20 Genentech Inc Compuestos a base de 2-amido-tiazol que exhiben actividad inhibidora de enzima que utiliza atp y composiciones y usos de los mismos.
EP1798229A4 (en) * 2004-09-07 2009-07-29 Sankyo Co SUBSTITUTED BIPHENYL DERIVATIVE
EP1799664A1 (en) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AR051026A1 (es) 2004-09-20 2006-12-13 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
BRPI0515505A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
WO2006101521A2 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
AU2006325706B2 (en) * 2005-12-16 2012-03-29 Novartis Ag Control of intraocular pressure using ALK5 modulation agents
WO2008150827A1 (en) * 2007-05-29 2008-12-11 Smithkline Beecham Corporation Naphthyridine, derivatives as p13 kinase inhibitors
WO2009111502A2 (en) 2008-03-03 2009-09-11 University Of Notre Dame Du Lac Anti-cancer compounds, synthesis thereof, and methods of using same
US8865732B2 (en) 2008-03-21 2014-10-21 Novartis Ag Heterocyclic compounds and uses thereof
AU2012203026B2 (en) * 2008-03-21 2014-06-12 Novartis Ag Novel heterocyclic compounds and uses thereof
US8338604B2 (en) 2008-06-20 2012-12-25 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
EP3089971B1 (en) 2014-01-01 2020-07-29 Medivation Technologies LLC Compounds and methods of use
UY36294A (es) 2014-09-12 2016-04-29 Novartis Ag Compuestos y composiciones como inhibidores de quinasa
CN105585565B (zh) * 2014-10-23 2019-10-01 中国医学科学院药物研究所 含2-苯胺基-4-噻唑基吡啶衍生物及其制法和药物组合物与用途
CN106243012A (zh) * 2016-08-02 2016-12-21 北方民族大学 新型吲哚类衍生物及其制备方法
ES2974991T3 (es) 2016-09-19 2024-07-02 Novartis Ag Combinaciones terapéuticas que comprenden un inhibidor de RAF y un inhibidor de ERK
KR102641827B1 (ko) 2017-05-02 2024-03-04 노파르티스 아게 병용 요법
KR102892521B1 (ko) * 2017-06-14 2025-11-27 트레베나, 인코포레이티드. S1p1 활성을 조정하기 위한 화합물 및 그를 사용하는 방법
US12187703B2 (en) 2019-05-13 2025-01-07 Novartis Ag Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer
CN112694477B (zh) * 2019-10-22 2024-02-06 四川科伦博泰生物医药股份有限公司 吡唑并环类化合物,包含其的药物组合物,其制备方法及其用途
CN114727977B (zh) 2019-11-19 2025-12-30 特维娜有限公司 化合物和化合物s1p1调节剂的制备方法
CN115466260B (zh) * 2022-09-06 2023-10-13 延边大学 含氨基酸结构的咪唑和噻唑类衍生物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149884B1 (en) 1983-09-09 1992-12-16 Takeda Chemical Industries, Ltd. 5-pyridyl-1,3-thiazole derivatives, their production and use
GB9201692D0 (en) 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
WO1998052941A1 (en) 1997-05-22 1998-11-26 G.D. Searle And Co. PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
CN1264376A (zh) 1997-05-22 2000-08-23 G·D·瑟尔公司 作为p38激酶抑制剂的3(5)-杂芳基取代的吡唑化合物
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
JPH11193281A (ja) 1997-10-27 1999-07-21 Takeda Chem Ind Ltd アデノシンa3受容体拮抗剤およびチアゾール化合物
DE60001229T2 (de) * 1999-04-09 2003-10-30 Smithkline Beecham Corp., Philadelphia Triarylimidazole
EP1205478A4 (en) 1999-08-06 2004-06-30 Takeda Chemical Industries Ltd P38MAP KINASE INHIBITORS
CO5271680A1 (es) 2000-02-21 2003-04-30 Smithkline Beecham Corp Compuestos
GB0007405D0 (en) 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
PE20020506A1 (es) 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0027987D0 (en) * 2000-11-16 2001-01-03 Smithkline Beecham Plc Compounds
US20040039198A1 (en) 2000-11-16 2004-02-26 Bender Paul E. Compounds
EP1354603A1 (en) 2000-12-26 2003-10-22 Takeda Chemical Industries, Ltd. Concomitant drugs
GB0100762D0 (en) 2001-01-11 2001-02-21 Smithkline Beecham Plc Novel use
GB0102668D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
WO2002062787A1 (en) 2001-02-02 2002-08-15 Glaxo Group Limited Pyrazoles as tgf inhibitors
JPWO2002062775A1 (ja) 2001-02-02 2004-06-10 山之内製薬株式会社 2−アシルアミノチアゾール誘導体又はその塩
GB0102672D0 (en) 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
ES2237671T3 (es) 2001-02-02 2005-08-01 Smithkline Beecham Corporation Derivados de pirazol contra la sobreexpresion de tgf.
GB0102673D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
GB0102665D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
US20050080113A1 (en) 2001-06-11 2005-04-14 Shigenori Ohkawa Medicinal compositions
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
GB0217787D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd C ompounds
WO2004013135A1 (en) 2002-07-31 2004-02-12 Smithkline Beecham Corporation 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
KR20050057393A (ko) 2002-09-18 2005-06-16 화이자 프로덕츠 인크. 전환 성장 인자 (tgf) 억제제로서 트리아졸 유도체
HRP20050246A2 (en) 2002-09-18 2005-10-31 Pfizer Products Inc. Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors
AU2003259475A1 (en) 2002-09-18 2004-04-08 Pfizer Products Inc. Pyrazole derivatives as transforming growth factor (TGF) inhibitors
CN1681805A (zh) 2002-09-18 2005-10-12 辉瑞产品公司 作为转化生长因子(tgf)抑制剂的新的咪唑类化合物

Similar Documents

Publication Publication Date Title
JP2006502235A5 (cg-RX-API-DMAC7.html)
JP2006506443A5 (cg-RX-API-DMAC7.html)
CA2499429A1 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
RU2348627C2 (ru) Ингибиторы тирозинкиназ
RU2401658C2 (ru) Гетероциклические ингибиторы аспартилпротеазы
IL278297B1 (en) Transmutable heterocyclic ptpn11 inhibitors
JP2010031025A5 (cg-RX-API-DMAC7.html)
CA2496295A1 (en) Novels pyrazole compounds as transforming growth factor (tgf) inhibitors
JP2011509949A5 (cg-RX-API-DMAC7.html)
JP2008535902A5 (cg-RX-API-DMAC7.html)
JP2009538897A5 (cg-RX-API-DMAC7.html)
JP2008535903A5 (cg-RX-API-DMAC7.html)
JP2007534695A5 (cg-RX-API-DMAC7.html)
JP2004528334A5 (cg-RX-API-DMAC7.html)
CY1113538T1 (el) Παραγωγα της 5-αμινο-2,4,7-τριοξο-3,4,7,8-τετραϋδρο-2η-πυριδο[2,3-d] πυριμιδινης και παρομοιες ενωσεις για την αγωγη του καρκινου
PE20130385A1 (es) Derivados del acido naft-2-ilacetico para tratar el sida
RU2004130488A (ru) Пиримидиновые производные
JP2007511535A5 (cg-RX-API-DMAC7.html)
JP2009526830A5 (cg-RX-API-DMAC7.html)
CA2475434A1 (en) Aromatic amino acid derivatives and medicinal compositions
JP2010513322A5 (cg-RX-API-DMAC7.html)
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
US11001581B2 (en) Compounds which inhibit RNA polymerase, compositions including such compounds, and their use
CA2530374A1 (en) Hsp90 family protein inhibitors
JP2006501201A5 (cg-RX-API-DMAC7.html)